Perioperative Safety of Aprotinin in Coronary Artery Bypass Graft Surgery John G. Augoustides Commentary 20 November 2012 Pages: 557 - 560
Benefit-Risk Assessment of Telithromycin in the Treatment of Community-Acquired Pneumonia Steven D. Brown Review Article 20 November 2012 Pages: 561 - 575
Memantine for the Treatment of Alzheimer’s Disease Martin R. FarlowStephen M. GrahamGustavo Alva Short Communication 20 November 2012 Pages: 577 - 585
Risk Management of Simvastatin or Atorvastatin Interactions with CYP3A4 Inhibitors Espen MoldenEva SkovlundPia Braathen Original Research Article 20 November 2012 Pages: 587 - 596
Ethnic Differences in the Risks of Adverse Reactions to Drugs Used in the Treatment of Psychoses and Depression Sara OrmerodSarah E. McDowellRobin E. Ferner Original Research Article 20 November 2012 Pages: 597 - 607
Influence of Regulatory Measures on the Rate of Spontaneous Adverse Drug Reaction Reporting in Italy Domenico MotolaAntonio VargiuNicola Montanaro Original Research Article 20 November 2012 Pages: 609 - 616
Safety of Low-Dose Aprotinin in Coronary Artery Bypass Graft Surgery Mario KluthJan U LuethKazuo Inoue Original Research Article 20 November 2012 Pages: 617 - 626
Occurrence of Community-Acquired Respiratory Tract Infection in Patients Receiving Esomeprazole Lennart EstbornSvante Joelson Original Research Article 20 November 2012 Pages: 627 - 636